These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1661695)

  • 1. Radioreceptor assay for advanced glycosylation end products.
    Radoff S; Makita Z; Vlassara H
    Diabetes; 1991 Dec; 40(12):1731-8. PubMed ID: 1661695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex.
    Vlassara H; Li YM; Imani F; Wojciechowicz D; Yang Z; Liu FT; Cerami A
    Mol Med; 1995 Sep; 1(6):634-46. PubMed ID: 8529130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells.
    Higashi T; Sano H; Saishoji T; Ikeda K; Jinnouchi Y; Kanzaki T; Morisaki N; Rauvala H; Shichiri M; Horiuchi S
    Diabetes; 1997 Mar; 46(3):463-72. PubMed ID: 9032104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor.
    Nagai R; Matsumoto K; Ling X; Suzuki H; Araki T; Horiuchi S
    Diabetes; 2000 Oct; 49(10):1714-23. PubMed ID: 11016456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocytic uptake of nonenzymatically glycosylated proteins is mediated by a scavenger receptor for aldehyde-modified proteins.
    Takata K; Horiuchi S; Araki N; Shiga M; Saitoh M; Morino Y
    J Biol Chem; 1988 Oct; 263(29):14819-25. PubMed ID: 2844787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties.
    Esposito C; Gerlach H; Brett J; Stern D; Vlassara H
    J Exp Med; 1989 Oct; 170(4):1387-407. PubMed ID: 2551990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction.
    Araki N; Higashi T; Mori T; Shibayama R; Kawabe Y; Kodama T; Takahashi K; Shichiri M; Horiuchi S
    Eur J Biochem; 1995 Jun; 230(2):408-15. PubMed ID: 7607209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
    Pugliese G; Pricci F; Romeo G; Pugliese F; Mené P; Giannini S; Cresci B; Galli G; Rotella CM; Vlassara H; Di Mario U
    Diabetes; 1997 Nov; 46(11):1881-7. PubMed ID: 9356040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.
    Schmidt AM; Yan SD; Brett J; Mora R; Nowygrod R; Stern D
    J Clin Invest; 1993 May; 91(5):2155-68. PubMed ID: 8387541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules.
    Vlassara H; Brownlee M; Cerami A
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5588-92. PubMed ID: 2994035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products and their recognition by macrophage and macrophage-derived cells.
    Horiuchi S; Higashi T; Ikeda K; Saishoji T; Jinnouchi Y; Sano H; Shibayama R; Sakamoto T; Araki N
    Diabetes; 1996 Jul; 45 Suppl 3():S73-6. PubMed ID: 8674898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-specific binding of advanced-glycosylation end-products to macrophages outweighs specific receptor-mediated interactions.
    Shaw SM; Crabbe MJ
    Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):121-9. PubMed ID: 7998922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin. Competition with advanced glycation end product-modified serum albumin at the advanced glycation end product receptor.
    Westwood ME; McLellan AC; Thornalley PJ
    J Biol Chem; 1994 Dec; 269(51):32293-8. PubMed ID: 7798229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo.
    Vlassara H; Brownlee M; Cerami A
    Diabetes; 1988 Apr; 37(4):456-61. PubMed ID: 2837419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.
    Skolnik EY; Yang Z; Makita Z; Radoff S; Kirstein M; Vlassara H
    J Exp Med; 1991 Oct; 174(4):931-9. PubMed ID: 1655949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding characteristics of reduced hepatic receptors for acetylated low-density lipoprotein and maleylated bovine serum albumin.
    Ottnad E; Via DP; Sinn H; Friedrich E; Ziegler R; Dresel HA
    Biochem J; 1990 Feb; 265(3):689-98. PubMed ID: 2154967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of pathways of advanced glycation end-products accumulation in macrophages.
    Nagai R; Fujiwara Y; Mera K; Otagiri M
    Mol Nutr Food Res; 2007 Apr; 51(4):462-7. PubMed ID: 17390398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor.
    Vlassara H; Moldawer L; Chan B
    J Clin Invest; 1989 Dec; 84(6):1813-20. PubMed ID: 2556447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors.
    Vlassara H; Brownlee M; Cerami A
    J Exp Med; 1986 Oct; 164(4):1301-9. PubMed ID: 3760778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products.
    Valencia JV; Mone M; Koehne C; Rediske J; Hughes TE
    Diabetologia; 2004 May; 47(5):844-52. PubMed ID: 15127201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.